252 related articles for article (PubMed ID: 31251552)
1. Connecting the Dots: From Skin Barrier Dysfunction to Allergic Sensitization, and the Role of Moisturizers in Repairing the Skin Barrier.
Strugar TL; Kuo A; Seité S; Lin M; Lio P
J Drugs Dermatol; 2019 Jun; 18(6):581. PubMed ID: 31251552
[TBL] [Abstract][Full Text] [Related]
2. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis.
Elias PM; Wakefield JS; Man MQ
Skin Pharmacol Physiol; 2019; 32(1):1-7. PubMed ID: 30336483
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of new mechanistic insights into atopic dermatitis.
Leung DY
Curr Opin Pediatr; 2016 Aug; 28(4):456-62. PubMed ID: 27191525
[TBL] [Abstract][Full Text] [Related]
4. The Microbiome and Atopic Dermatitis: A Review.
Pothmann A; Illing T; Wiegand C; Hartmann AA; Elsner P
Am J Clin Dermatol; 2019 Dec; 20(6):749-761. PubMed ID: 31444782
[TBL] [Abstract][Full Text] [Related]
5. Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties.
Capone K; Kirchner F; Klein SL; Tierney NK
J Drugs Dermatol; 2020 May; 19(5):524-531. PubMed ID: 32484623
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Microbiome Dysbiosis and Bacterial Biofilms on Epidermal Barrier Function in Atopic Dermatitis-An Update.
Blicharz L; Rudnicka L; Czuwara J; Waśkiel-Burnat A; Goldust M; Olszewska M; Samochocki Z
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445108
[TBL] [Abstract][Full Text] [Related]
7. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis.
Dainichi T; Kitoh A; Otsuka A; Nakajima S; Nomura T; Kaplan DH; Kabashima K
Nat Immunol; 2018 Dec; 19(12):1286-1298. PubMed ID: 30446754
[TBL] [Abstract][Full Text] [Related]
8. The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin Barrier.
Baldwin HE; Bhatia ND; Friedman A; Eng RM; Seite S
J Drugs Dermatol; 2017 Jan; 16(1):12-18. PubMed ID: 28095528
[TBL] [Abstract][Full Text] [Related]
9. Contact haptens in emollients marketed in two European countries (Poland and Spain).
Kunkiel K; Sojewska M; Feleszko W
Allergol Immunopathol (Madr); 2020; 48(6):814-818. PubMed ID: 32460993
[TBL] [Abstract][Full Text] [Related]
10. The Skin Microbiome in Atopic Dermatitis and Its Relationship to Emollients.
Lynde CW; Andriessen A; Bertucci V; McCuaig C; Skotnicki S; Weinstein M; Wiseman M; Zip C
J Cutan Med Surg; 2016 Jan; 20(1):21-8. PubMed ID: 26492918
[TBL] [Abstract][Full Text] [Related]
11. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention.
Simpson EL; Chalmers JR; Hanifin JM; Thomas KS; Cork MJ; McLean WH; Brown SJ; Chen Z; Chen Y; Williams HC
J Allergy Clin Immunol; 2014 Oct; 134(4):818-23. PubMed ID: 25282563
[TBL] [Abstract][Full Text] [Related]
12. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends.
Hendricks AJ; Mills BW; Shi VY
J Dermatol Sci; 2019 Aug; 95(2):56-61. PubMed ID: 31395434
[TBL] [Abstract][Full Text] [Related]
13. Exogenous Factors in Skin Barrier Repair.
Schwartz J; Friedman AJ
J Drugs Dermatol; 2016 Nov; 15(11):1289-1294. PubMed ID: 28095538
[TBL] [Abstract][Full Text] [Related]
14. Proderm technology: a water- based lipid delivery system for dermatitis that penetrates viable epidermis and has antibacterial effects.
Charruyer A; Silvander M; Caputo-Janhager M; Raymond I; Ghadially R
BMC Dermatol; 2019 Jan; 19(1):2. PubMed ID: 30670022
[TBL] [Abstract][Full Text] [Related]
15. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
16. The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair.
Rajkumar J; Chandan N; Lio P; Shi V
Skin Pharmacol Physiol; 2023; 36(4):174-185. PubMed ID: 37717558
[TBL] [Abstract][Full Text] [Related]
17. Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: Unmet needs and open questions.
Darlenski R; Kozyrskyj AL; Fluhr JW; Caraballo L
J Allergy Clin Immunol; 2021 Dec; 148(6):1387-1393. PubMed ID: 34688495
[TBL] [Abstract][Full Text] [Related]
18. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.
Zhu TH; Zhu TR; Tran KA; Sivamani RK; Shi VY
Br J Dermatol; 2018 Sep; 179(3):570-581. PubMed ID: 29761483
[TBL] [Abstract][Full Text] [Related]
19. Host-microbial dialogues in atopic dermatitis.
Kobayashi T; Nagao K
Int Immunol; 2019 Jul; 31(7):449-456. PubMed ID: 30877745
[TBL] [Abstract][Full Text] [Related]
20. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
Bomstein Y; Rozenblat S
J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
